https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-04-06 / J Gynecol Oncol 2021 Jul;32(4):e59
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-04-06 / J Gynecol Oncol 2021 Jul;32(4):e592021-04-06 00:00:002021-04-06 00:00:00Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-04-06 / Cancers (Basel) 2021 Apr;13(7)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-04-06 / Cancers (Basel) 2021 Apr;13(7)2021-04-06 00:00:002021-04-06 00:00:00Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-30 / Int J Med Sci 2021;18(11):2294-2302
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-30 / Int J Med Sci 2021;18(11):2294-23022021-03-30 00:00:002023-01-31 13:10:47Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-29 / Front Immunol 2021;12:641307
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-29 / Front Immunol 2021;12:6413072021-03-29 00:00:002021-03-29 00:00:00Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-26 / Int J Pharm 2021 Mar;:120534
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-26 / Int J Pharm 2021 Mar;:1205342021-03-26 00:00:002021-03-26 00:00:00Curcumin encapsulation in nanostructures for cancer therapy: a 10-year overview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-17 / Mol Clin Oncol 2021 May;14(5):103
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-17 / Mol Clin Oncol 2021 May;14(5):1032021-03-17 00:00:002023-01-31 15:58:55Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-13 / Cancers (Basel) 2021 Mar;13(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-13 / Cancers (Basel) 2021 Mar;13(6)2021-03-13 00:00:002021-03-13 00:00:00Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-13 / J Neurooncol 2021 May;152(3):419-428
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-13 / J Neurooncol 2021 May;152(3):419-4282021-03-13 00:00:002021-03-13 00:00:00Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-12 / Cancers (Basel) 2021 Mar;13(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-12 / Cancers (Basel) 2021 Mar;13(6)2021-03-12 00:00:002021-03-12 00:00:00Hyperthermia-Based Anti-Cancer Treatments
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-10 / Int J Mol Sci 2021 Mar;22(6)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-10 / Int J Mol Sci 2021 Mar;22(6)2021-03-10 00:00:002021-03-10 00:00:00Cell Therapies in Bladder Cancer Management
